DOT1L and breast carcinoma: Given that H3K79 methylation is a master regulator for gene transcription, a whole-genome profiling was performed to determine how DOT1L inhibition changes gene expression, in order to find the mechanism by which these compounds reduce proliferation of breast cancer cells.